4//SEC Filing
PROGENICS PHARMACEUTICALS INC 4
Accession 0001447348-14-000014
CIK 0000835887operating
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 3:32 PM ET
Size
5.1 KB
Accession
0001447348-14-000014
Insider Transaction Report
Form 4
Youssoufian Hagop
Executive Vice President R&D
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2014-03-03$4.70/sh+66,000$310,200→ 66,000 totalExercise: $4.70Exp: 2024-03-03→ Common Stock (66,000 underlying)
Footnotes (1)
- [F1]The stock options become exercisable in three equal annual installments, commencing one year from the grant date.
Documents
Issuer
PROGENICS PHARMACEUTICALS INC
CIK 0000835887
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000835887
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 3:32 PM ET
- Size
- 5.1 KB